Santhera Pharmaceuticals Holding AG (SANN)
Market Closed
10 Aug, 15:20
16. 40
CHF +0.56
+3.5354%
215.06M Market Cap
- P/E Ratio
- Div Yield
123,440 Volume
-6.11 Eps
15.84 CHF
Previous Close Want to track SANN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Santhera Pharmaceuticals Holding AG (SANN) Statistics
Valuation metrics
Market Cap 215.06M
Enterprise value 310.26M
Trailing P/E (ttm) -4.15
Forward P/E 21.79
PEG ratio 0.14
Price/Sales (ttm) 3.04
Price/Book (mrq) -17.96
Enterprise Value/Revenue 4.02
Enterprise Value/EBITDA -10.13
Overview
Shares outstanding 13.39M
Float 10.23M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.09%
Average volume (10 days) 105.04K
Average volume (90 days) 65.1K
Price summary
52-Week low 9.38
52-Week high 18.84
Beta -0.42
50-Day moving average 15.21
200-Day moving average 15.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Jul 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2018
Profitability
Profit margin -0.64%
Operating margin -0.49%
Operational effectiveness
Return on assets -0.33%
Return on equity 6.85%
Income Statement
Revenue (ttm) 49.02M
Revenue per share (ttm) 5.76
Quarterly revenue growth (yoy) 0.7%
Gross profit (ttm) 6.57M
EBITDA -45.63M
Net income to common (ttm) -65.54M
Diluted EPS (ttm) -3.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 18.4M
Total cash per share (mrq) 1.68
Total debt (mrq) 41.22M
Total Debt/Equity (mrq) -8.27
Current ratio (mrq) 1.29%
Book value per share (mrq) -0.88
Cash Flow
Cash flow statement -40.84M
Levered free cash flow (LFCF) -29.87M
